Additional experience related to scientific activity/clinical trials — publications and oral presentations:
Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort study. TIMO F. W. SOETERIK, MARCIN MISZCZYK, MAX PETERS, MATEUSZ BILSKI, GIULIO FRANCOLINI, PIETRO GARLATTI, LUCA NICOSIA, FILIPPO ALONGI, MĀRIS MEŽECKIS, JUSTYNA KOCIOŁEK, CARLO GRECO, TOMASZ TECHMAŃSKI, ELINE H. HUELE, FREDERIK R. TEUNISSEN, PAULIEN WESTHOFF, WESSEL VIS, MARIE A. D. HAVERKORT, JOCHEM R N VAN DER VOORT VAN ZYP, MARTIJN INTVEN, JOANNE M VAN DER VELDEN, SHAHROKH F. SHARIAT, WIETSE S.C. EPPINGA. Lancet Oncol. [online] 2026 s. 1-10, 30, https://www.sciencedirect.com/science/article/pii/S147020452500717X. DOI: 10.1016 s1470-2045(25)00717-x
Balancing efficacy and toxicity in salvage brachytherapy and SBRT for radio-recurrent prostate cancer: insights beyond the UroGEC review. MATEUSZ BILSKI, JACEK FIJUTH, ŁUKASZ KUNCMAN. Technol. Cancer Res. Treat. 2026 vol. 25 s. 1-3. DOI: 10.1177/15330338261415791
Real-world patients management and referral patterns in patients with stage III unresectable non-small cell lung cancer in Poland. ŁUKASZ KUNCMAN, MATEUSZ BILSKI, KATARZYNA KONAT-BĄSKA, MAJA LISIK-HABIB, MATEUSZ PAJDZIŃSKI, AGNIESZKA SAMBORSKA, JACEK FIJUTH. JCO Glob. Oncol. [online] 2026 vol. 12 [art. nr] e2500189, s. 1-14, 33, https://ascopubs.org/doi/10.1200/GO-25-00189. DOI: 10.1200/GO-25-00189
Combined radiochemotherapy for stage III non-small cell lung cancer – recommendations of the Polish Lung Cancer Group, the Polish Society of Clinical Oncology, the Polish Society of Oncological Radiotherapy, the Polish Society of Pathologists and the Polish Society of Respiratory Diseases regarding diagnosis, qualification and treatment. DARIUSZ M. KOWALSKI, RENATA LANGFORT, PAWEŁ KRAWCZYK, KAMILA WOJAS-KRAWCZYK, DAMIAN TWOREK, KATARZYNA GALWAS, ŁUKASZ KUNCMAN, KATARZYNA BŁASIŃSKA, ADAM PŁUŻAŃSKI, MAGDALENA KNETKI-WRÓBLEWSKA, MACIEJ KRZAKOWSKI, RODRYG RAMLAU, JACEK FIJUTH, RAFAŁ SUWIŃSKI, MATEUSZ BILSKI, RAFAŁ KRENKE, IZABELA CHMIELEWSKA, TADEUSZ ORŁOWSKI, ADAM ANTCZAK, PIOTR JAŚKIEWICZ, CEZARY PIWKOWSKI, KATARZYNA STENCEL. Onkol. Prakt. Klin. Eduk. [online] 2026 t. 12, e04926015, s. 1-23, 91, sum, https://journals.viamedica.pl/onkologia_w_praktyce_klin_edu/article/view/109489. DOI: 10.5603/owpk_edu.109489
Survival outcomes and toxicity profile after CT-guided HDR brachytherapy (interventional radiotherapy) for liver oligometastases in breast cancer patients: the BRALIBREST real world multicenter study. MATEUSZ BILSKI, ŁUKASZ KUNCMAN, [AUT.] MAGDALENA ORZECHOWSKA, PAWEŁ CISEK, FEDERICO MASTROLEO, MIKOŁAJ SKRZYPCZAK, SYLWIA SROKA, EWA WOJTYNA, KONSTANTINOS FERENTINOS, KATHRIN HERING, JACEK FIJUTH, BARBARA A. JERECZEK-FOSSA, HAI MINH HA, DANIEL MEDENWALD, MATTHIAS P. FABRITIUS, STEFANIE CORRADINI, MAX SEIDENSTICKER, JENS RICKE, MACIEJ PECH, [AUT. KORESP.] FREDERIK FUCHS, PAUL ROGOWSKI. Radiother. Oncol. 2026 vol. 214 ,111280, s. 1-9, 34, https://www.sciencedirect.com/science/article/pii/S0167814025052843. DOI: 10.1016/j.radonc.2025.111280
Real-world survival and prognostic factors in WHO 2021 classified gliomas treated with chemo-radiotherapy. MATEUSZ BILSKI, GEORGES NOËL, KRZYSZTOF SMÓŁKA, KATARZYNA KUNCEWICZ, WOJCIECH KUŹNICKI, LOIC FEUVRET, KATARZYNA KORAB, MAGDALENA PESZYŃSKA-PIORUN, PAWEŁ KORONA, IZABELA BARANOWSKA, AGATA SULEJA, CLARA LE FEVRE, ROLAND SCHOTT, LAURA SOMME, SALMA CHABLI, EMMANUEL MESNY, FEDERICO MASTROLEO, RUPESH KOTECHA, JAKUB JURKIEWICZ, JACEK FIJUTH, BARBARA A. JERECZEK-FOSSA, KAMIL KRYSTKIEWICZ, MACIEJ HARAT, ŁUKASZ KUNCMAN. Sci. Rep. 2025 vol. 15, 380117, s. 1-15, 61. https://www.nature.com/articles/s41598-025-21934-2. DOI: 10.1038/s41598-025-21934-2
MUlticentre REtrospective comparison of definitive EBRT with or without HDR BRAchytherapy boost in patients with locally-advanced prostate cancer and regional lymph NOde metastases (MUREBRANO) — a propensity score matched analysis. MATEUSZ BILSKI, PIOTR LELEK, MAGDALENA STANKIEWICZ, MARCIN MISZCZYK, WOJCIECH BURCHARDT, ADAM KLUSKA, ALEKSANDRA NAPIERALSKA, ANDRZEJ KUKIEŁKA, PAWEŁ CISEK, KATARZYNA KONAT-BĄSKA, RAFAŁ STANDO, MICHAŁ DEC, EWELINA PILISZCZUK, ROBERT MATYS, TOMASZ BAJON, MACIEJ TROJANOWSKI, MATHIAS MOLL, ALFONSO GOMEZ-ITURRIAGA, ADAM CHICHEŁ, PIOTR WOJCIESZEK, SHAHROKH F. SHARIAT, ARTUR CHYREK. Radiother. Oncol. 2025 vol. 212, 111112, s. 1-7, 40, https://www.sciencedirect.com/science/article/piiS016781402504616X. DOI: 10.1016/j.radonc.2025.111112
High-Dose-Rate brachytherapy for salvage treatment of prostate cancer Recurrence Post-Prostatectomy and Radiotherapy: a multicenter retrospective analysis (HDR-REPOPRA) by UroGEC. ADAM KLUSKA, ARTUR J. CHYREK, BENJAMIN GUIX, PATRICIA WILLISCH, TAMER SOROR, MATEUSZ BILSKI, IVAN GARCIA, TERESA GUIX, BEATRIZ VÁZQUEZ, WOJCIECH BURCHARDT, PIOTR LELEK, RICARDA MERTEN, VRATISLAV STRNAD, IOSIF STROUTHOS, MARIO TERLIZZI, DAVID BÜCHSER, PIERRE BLANCHARD, ALFONSO GOMEZ-ITURRIAGA, PIOTR WOJCIESZEK. Radiother. Oncol. 2025, 111145, s. 1-15, 7, https://www.sciencedirect.com/science/article/pii/S0167814025046493. DOI: 10.1016/j.radonc.2025.111145
Algorithm for the Management of a Solitary Pulmonary Nodule: A Radiation Oncologist’s Perspective. Mateusz Bilski. Lecture in: XIX Polish Lung Cancer Society Congress, 20-22.11.25, Warsaw, Poland
Salvage HDR-brachytherapy for prostate cancer recurrence: outcomes, predictors, and toxicity profile in a PSMA-PET selected cohort. MATEUSZ BILSKI, K. KUNCEWICZ, P[AWEŁ] CISEK. Eur. Urol. Open Sci. 2025 vol. 81 suppl. s. S116, 17th European Multidisciplinary Congress on Urological Cancers. Prague, 13-16 November 2025. DOI: 10.1016/S2666-1683(25)01534-4
The predictors of response to metastasis-directed therapy with SBRT in PSMA PET/CT staged oLigorecurrent prostate cancer (PORTAL) study: development and external validation of a nomogram-based risk classification. TIMO SOETERIK, M. MISZCZYK, M. PETERS, MATEUSZ BILSKI, G. FRANCOLINI, P. GARLATTI, L. NICOSIA, M. MEZECKIS, J. KOCIOŁEK, C. GRECO, T. TECHMAŃSKI, E. HUELE, F. TEUNISSEN, P. WESTHOFF, P. KROON, W. VIS, D. HAVERKORT, VAN DER VOORT VAN ZYP J.R.N., M. INTVEN, VAN DER VELDEN J.M., S.F. SHARIAT, W. EPPINGA. Eur. Urol. Open Sci. 2025 vol. 81 suppl. s. S227, 17th European Multidisciplinary Congress on Urological Cancers. Prague, 13-16 November 2025. DOI: 10.1016/S2666-1683(25)01616-7
Real-world oncological outcomes and toxicity of metastasis-directed therapy for synchronous oligometastatic prostate cancer (ATTENTION). MAGDALENA STANKIEWICZ, MATEUSZ BILSKI, I. BANASZEK, K. KUNCEWICZ, L. KUNCMAN, K. BUŁACZ, G. FRANCOLINI, P. GARLATTI, M. AQUILANO, D. KAZBERUK, A. SZMIGIEL-TRZCIŃSKA, A. KUKIEŁKA, K. KONAT-BĄSKA, M. SZLAG, P. WOJCIESZEK. Eur. Urol. Open Sci. 2025 vol. 81 suppl. s. S220, 17th European Multidisciplinary Congress on Urological Cancers. Prague, 13-16 November 2025. DOI: 10.1016/S2666-1683(25)01611-8
Tailoring Nodal Radiotherapy in regionally advanced prostate cancer: a multicenter study of dose escalation outcomes based on PSMA PET vs. conventional imaging. MATEUSZ BILSKI, F. MASTROLEO, A. CHYREK, Ł. KUNCMAN, P. LELEK, M. STANKIEWICZ, A. GOMEZ-ITURRIAGA, M. MISZCZYK, W. BURCHARDT, A. KLUSKA, A. NAPIERALSKA, A. KUKIEŁKA, K. KONAT-BĄSKA, R. STANDO, M. DEC, E. PILISZCZUK, R. MATYS, T. BAJON, M. TROJANOWSKI, A. CHICHEŁ, P. WOJCIESZEK, J. FIJUTH, A. KISHAN, B.A. JERECZEK-FOSSA. Eur. Urol. Open Sci. 2025 vol. 81 suppl. s. S166, 17th European Multidisciplinary Congress on Urological Cancers. Prague, 13-16 November 2025. DOI: 10.1016/S2666-1683(25)01570-8
Multicentre retrospective comparison of definitive EBRT with or without HDR brachytherapy boost in patients with locally-advanced prostate cancer and regional lymph node metastases — a propensity score matched analysis. MATEUSZ BILSKI, P. LELEK, M. STANKIEWICZ, M. MISZCZYK, W. BURCHARDT, A. KLUSKA, A. NAPIERALSKA, A. KUKIEŁKA, P[AWEŁ] CISEK, K. KONAT-BĄSKA, R. STANDO, M. DEC, E. PILISZCZUK, R. MATYS, T. BAJON, M. TROJANOWSKI, M. MOLL, A. GOMEZ-ITURRIAGA, A. CHICHEŁ, P. WOJCIESZEK, A. CHYREK. Eur. Urol. Open Sci. 2025 vol. 81 suppl. s. S165, 17th European Multidisciplinary Congress on Urological Cancers. Prague, 13-16 November 2025. DOI: 10.1016/S2666-1683(25)01569-1
Real-world survival outcomes after (chemo)radiotherapy for who 2021-classified gliomas: a multicenter analysis of clinical, treatment-related, dosimetric, and hematologic prognostic factors. MATEUSZ BILSKI, G. NOEL, K. SMÓŁKA, K. KUNCEWICZ, W. KUŹNICKI, L. FEUVRET, K. KORAB, M. PESZYŃSKA-PIORUN, P[AWEŁ] KORONA, I[ZABELA] BARANOWSKA, A. SULEJA, F. MASTROLEO, R. KOTECHA, J. JURKIEWICZ, J. FIJUTH, B. A. JERECZEK-FOSSA, K. KRYSTKIEWICZ, Ł. KUNCMAN. Neuro-Oncology, 2025 vol. 27 Suppl. 3 s. iii181, 20th Meeting of the European Association of Neuro-Oncology. Prague, October 16-19, 2025. https://academic.oup.com/neuro-oncology/article/27/Supplement_3/iii181/8272131, DOI: 10.1093/neuonc/noaf193.612
Mapping early failure after CRT and durvalumab in NSCLC: insights from a real-world cohort. M. LISIK-HABIB, K. SMÓŁKA, R. STANDO, MATEUSZ BILSKI, K. GALWAS-KLIBER, D. TWOREK, A. ROMAN, M. PÜSKÜLLÜOĞLU, J. FIJUTH, Ł. KUNCMAN. J. Thorac. Oncol. 2025 vol. 20 nr 10 suppl. 1 s. S349-S350, 2025 World Conference on Lung Cancer. Barcelona, 06 September – 09 September 2025. DOI: 10.1016/j.jtho.2025.09.657
How to Escalate the Dose in Node-Positive Prostate Cancer — Brachytherapy, Stereotactic Radiotherapy, or SIB? Mateusz Bilski. Lecture presented at the scientific meeting “Where Is Modern Radiotherapy Heading – Dose Escalation or De-escalation? Optimal Sequencing of Multimodal Cancer Treatment Involving Radiotherapy”, Radiation oncologists for radiation oncologists, 4R congress, Warsaw, Poland, 10-11.10.2025
Adjuvant Radiotherapy in the Era of Perioperative Treatment for Non-Small Cell Lung Cancer (NSCLC). Mateusz Bilski. Lecture presented at the “Autumn Excellence Conference – Lung Cancer, Thoracic Tumours, Skin, Melanoma Cancers and Others”, Wrocław, Poland, September 26–27, 2025
Computer-aided target volume delineation for postoperative radiation therapy in brain glioma patients with the use of the hybrid artificial intelligence model. MATEUSZ BILSKI, [AUT.] MATEUSZ BUŁAT, IZABELA BARANOWSKA, MAGDALENA PESZYŃSKA-PIORUN, ŁUKASZ KUNCMAN, JACEK FIJUTH, JANUSZ JUREK. Eur. Phys. J. Spec. Top. 2025 s. 1-10, 29. https://link.springer.com/article/10.1140/epjs/s11734-025-01688-8. DOI: 10.1140/epjs/s11734-025-01688-8
Interventional stereotactic radiotherapy (brachytherapy) for unresected brain metastases: systematic review of outcome and toxicity. MATEUSZ BILSKI, FEDERICO MASTROLEO, [AUT. KORESP.] ŁUKASZ KUNCMAN, PAUL ROGOWSKI, STEFANO DURANTE, COSTANTINO PUTZU, ARTUR CHYREK, GIULIA MARVASO, BRUNO FIONDA, LUCA TAGLIAFERII, JACEK FIJUTH, ANDREA VAVASSORI, RANJINI TOLAKANAHALLI, BARBARA A. JERECZEK-FOSSA, RUPESH KOTECHA. Crit. Rev. Oncol. Hematol. 2025 vol. 212, 104777, 1-11, 37, https://www.sciencedirect.com/science/article/pii/S1040842825001659. DOI: 10.1016/j.critrevonc.2025.104777
Computed tomography guided high dose rate brachytherapy for induced oligoprogression of colorectal cancer liver metastases. PAWEŁ CISEK, ŁUKASZ KUNCMAN, [AUT.] BARBARA A. JERECZEK-FOSSA, EWA WOJTYNA, MAGDALENA ORZECHOWSKA, SYLWIA SROKA, IZABELA KORDZIŃSKA-CISEK, JACEK FIJUTH, MATEUSZ BILSKI. Sci. Rep. 2025 vol. 15, 22735, s. 1-11, 34, https://www.nature.com/articles/s41598-025-09227-0. DOI: 10.1038/s41598-025-09227-0
Radiotherapy integration strategy for small-cell lung cancer in extensive stage (RISE) with up to 10 metastases: a study protocol of a randomized phase II trial. ŁUKASZ KUNCMAN, JACEK FIJUTH, DAMIAN TWOREK, EWA SIERKO, PAWEŁ CISEK, MICHAŁ MASŁOWSKI, MAJA LISIK-HABIB, MAGDALENA ORZECHOWSKA, KATARZYNA GALWAS-KLIBER, ADAM ANTCZAK, IZABELA CHMIELEWSKA, BARBARA ZIÓŁKOWSKA, MARTA KURCZEWSKA-MICHALAK, WOJCIECH KUŹNICKI, NINA JĘDRZEJCZAK, KINGA RANOSZEK, MATEUSZ BILSKI. J. Clin. Oncol. 2025 vol. 43 nr 16 suppl., 2025 ASCO Annual Meeting. [Chicago, May 30 – June 3, 2025]. Abstr. DOI: 10.1200/JCO.2025.43.16_suppl.TPS8125
EORTC/ESTRO defined induced oligopersistence of liver metastases from colorectal cancer – outcomes and toxicity profile of computer tomography guided high-dose-rate brachytherapy. [AUT.] PAWEŁ CISEK, MATEUSZ BILSKI, JULIA PONIKOWSKA, EWA WOJTYNA, JACEK FIJUTH, [AUT. KORESP.] ŁUKASZ KUNCMAN. Clin. Exp. Metastasis 2025 vol. 42 nr 3 [art. nr] 29, s. 1-13, 27, https://link.springer.com/10.1007/s10585-025-10348-z. DOI: 10.1007/s10585-025-10348-z
Radiotherapy(R) Integration(I) Strategy for Small(S)-Cell Lung Cancer in Extensive(E) Stage (RISE) with up to 10 metastases – a study protocol of a randomized phase II trial. ŁUKASZ KUNCMAN, JACEK FIJUTH, DAMIAN TWOREK, EWA SIERKO, PAWEŁ CISEK, MICHAŁ MASŁOWSKI, MAJA LISIK-HABIB, MAGDALENA ORZECHOWSKA, KATARZYNA GALWAS-KLIBER, ADAM ANTCZAK, IZABELA CHMIELEWSKA, BARBARA ZIÓŁKOWSKA, MARTA KURCZEWSKA-MICHALAK, WOJCIECH KUŹNICKI, NINA JĘDRZEJCZAK, KINGA RANOSZEK, [AUT. KORESP.] BILSKI MATEUSZ. BMC Cancer. 2025 vol. 25, 142, 1-10, 27, https://bmccancer.biomedcentral.com/articles/10.1186/s12885-025-13552-y. DOI: 10.1186/s12885-025-13552-y
Lecturer and Workshop Instructor in Workshop: Contouring in Prostate Cancer Radiotherapy. Three lectures: 1. Prostate Contouring Principles2. Post-Prostatectomy Fossa Contouring 3. Lymph Node Contouring in N1/M1a Scenarios. Supervision and individual instruction at contouring workstations during practical workshops. 30–31.05.2025, Warsaw, Poland
The role of brachytherapy in prostate cancer recurrence after radical radiotherapy-own experience and results of current studies. Mateusz Bilski. Mission Possible. Precision and Personalization Congress.16-17.05.2025.Warsaw, Poland
Reirradiation Of gynecological recurrences with HDR brachytherapy/interventional radiotherapy (I-RT) – a single institution analysis. [AUT.] MATEUSZ BILSKI, PAULINA MARCYNIUK, MONIKA BILSKA, PAWEŁ CISEK. Int. J. Gynecol. Cancer [online] 2025 vol. 35 nr 2 suppl. 1 100707, ESGO 2025 Congress. Rome, February 20-23, 2025. https://www.sciencedirect.com/science/article/abs/pii/S1048891X24212032. DOI: 10.1016/j.ijgc.2024.100707
Interventional radiotherapy (I-RT) for liver oligometastatic disease from colorectal cancer — a single institution retrospective analysis. MATEUSZ BILSKI, KATARZYNA KORAB, MAGDALENA ORZECHOWSKA, JULIA PONIKOWSKA, PAWEŁ CISEK, JACEK FIJUTH, ŁUKASZ KUNCMAN. Radiother. Oncol. [online] 2025 vol. 206 suppl. 1 s. S174, Transformative innovation through partnership: ESTRO 2025. Vienna, 2-6 May 2025. https://www.estro.org/Congresses/ESTRO-2025
Acute and late toxicity profile of liver interventional radiotherapy after direct (non-Seldinger) type of application – a single institution analysis. [AUT.] MATEUSZ BILSKI, KATARZYNA KORAB, JULIA PONIKOWSKA, ŁUKASZ KUNCMAN, JACEK FIJUTH, PAWEŁ CISEK. Radiother. Oncol. 2025 vol. 206 suppl. 1 s. S175, Transformative innovation through partnership: ESTRO 2025. Vienna, 2-6 May 2025. https://www.estro.org/Congresses/ESTRO-2025
A dosimetric comparison of different radiotherapy modalities for non-resected liver metastases. [AUT.] CAS STEFAAN DEJONCKHEERE, MATEUSZ BILSKI, YOUNÈSS NOUR, DAVIDE SCAFA, PAWEŁ CISEK, KATARZYNA KORAB, JULIA PONIKOWSKA, EWA RĘBACZ, SYLWIA SROKA, FABIAN KUGEL, MOLINA GRIMMER, JASMIN HOLZ, STEPHAN GARBE, PATRICK EICH, ELENI GKIKA, GUSTAVO RENATO SARRIA, JULIAN P. LAYER. Radiother. Oncol. 2025 vol. 206 suppl. 1 s. S176-S177, Transformative innovation through partnership : ESTRO 2025. Vienna, 2-6 May 2025. https://www.estro.org/Congresses/ESTRO-2025
Best Young researcher awarded abstract during ESTRO 2025 and top 5% abstracts submitted to ESTRO 2025 award. Target volume definition and organ at risk delineation in HDR brachytherapy for rectal cancer — consensus-based GEC-ESTRO guidelines. ANNE VALKENBURG, EVERT-JAN VAN LIMBERGEN, ANE APPELT, JOHANNES KNOTH, MAXIMILIAN A. SCHMID, NIKOS TSELIS, PETER HASS, RAHUL KRISHNATRY, REENA ENGINEER, BRUNO FIONDA, MARIA A. GAMBACORTA, BAUKELIEN VAN TRIEST, CLAUDIA SCHUURHUIZEN, KAREN J. NEELIS, MATEUSZ BILSKI, RAJARAM SRIPADAM, ALEXANDRA STEWART, MAAIKE BERBÉE. Radiother. Oncol. 2025 vol. 206 suppl. 1 s. S186-S189, Transformative innovation through partnership : ESTRO 2025. Vienna, 2-6 May 2025. https://www.estro.org/Congresses/ESTRO-2025
Top 5% abstracts submitted to ESTRO 2025 award. Outcomes of SBRT for PSMA PET diagnosed hormone-sensitive oligorecurrent prostate cancer: results from a large international multi-center cohort. [AUT.] TIMO F.W. SOETERIK, MARCIN MISZCZYK, MAX PETERS, MATEUSZ BILSKI, GIULIO FRANCOLINI, PIETRO GARLATTI, MĀRIS MEŽECKIS, JUSTYNA KOCIOŁEK, CARLO GRECO, TOMASZ TECHMANSKI, ELINE HUELE, FREEK TEUNISSEN, PAULIEN WESTHOFF, PETRA KROON, WESSEL VIS, DORIEN R.N. HAVERKORT, JOCHEM VAN DER VOORT VAN ZYP, MARTIJN INTVEN, JOANNE M VAN DER VELDEN, WIETSE S.C. EPPINGA. Radiother. Oncol. 2025 vol. 206 suppl. 1 s. S1975-S1976, Transformative innovation through partnership : ESTRO 2025. Vienna, 2-6 May 2025. https://www.estro.org/Congresses/ESTRO-2025
Development and internal validation of a nomogram predicting ADT-free survival in oligorecurrent prostate cancer treated with metastasis-directed SBRT. TIMO F.W. SOETERIK, MARCIN MISZCZYK, MAX PETERS, MATEUSZ BILSKI, GIULIO FRANCOLINI, PIETRO GARLATTI, MĀRIS MEŽECKIS, JUSTYNA KOCIOŁEK, CARLO GRECO, TOMASZ TECHMANSKI, ELINE HUELE, FREEK TEUNISSEN, PAULIEN WESTHOFF, PETRA KROON, WESSEL VIS, DORIEN HAVERKORT, JOCHEM R.N. VAN DER VOORT VAN ZYP, MARTIJN INTVEN, JOANNE VAN DER VELDEN, WIETSE S.C. EPPINGA. Radiother. Oncol. 2025 vol. 206 suppl. 1 s. S1997-S1998, Transformative innovation through partnership : ESTRO 2025. Vienna, 2-6 May 2025. https://www.estro.org/Congresses/ESTRO-2025
Advances in breast cancer treatment: a systematic review of preoperative stereotactic body radiotherapy (SBRT) for breast cancer. MATEUSZ BILSKI, KATARZYNA KONAT-BĄSKA, MARIA A. ZERELLA, STEFANIE CORRADINI, MARCIN HETNAŁ, MARIA C. LEONARDI, MARTYNA GRUBA, ALEKSANDRA GRZYWACZ, PATRYCJA HATALA, BARBARA A. JERECZEK-FOSSA, JACEK FIJUTH, ŁUKASZ KUNCMAN. Radiat. Oncol. [online] 2024 vol. 19 [art. nr] 103, s. 1-22, 87, https://ro-journal.biomedcentral.com/articles/10.1186/s13014-024-02497-4. DOI: 10.1186/s13014-024-02497-4
HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases – a dosimetric comparison study of three radioablative techniques. MATEUSZ BILSKI, KATARZYNA KORAB, MAŁGORZATA STĄPÓR-FUDZIŃSKA, JULIA PONIKOWSKA, AGNIESZKA BRZOZOWSKA, ŁUKASZ SROKA, EWA WOJTYNA, SYLWIA SROKA, MARTA SZLAG, PAWEŁ CISEK, [AUT. KORESP.] ALEKSANDRA NAPIERALSKA. Clin. Transl. Radiat. Oncol. [online] 2024 vol. 48 [art. nr] 100815, s. 1-9, 30. https://www.ctro.science/article/ S2405-6308(24)00092-2/fulltext. DOI: 10.1016/j.ctro.2024.100815
Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer. [AUT. KORESP.] ŁUKASZ KUNCMAN, [AUT.] MATEUSZ PAJDZIŃSKI, KRZYSZTOF SMÓŁKA, MATEUSZ BILSKI, JOANNA SOCHA, RAFAŁ STANDO, MAGDALENA PESZYŃSKA-PIORUN, KATARZYNA KORAB, BARBARA A. JERECZEK-FOSSA, JACEK FIJUTH. Front. Immunol. [online] 2024 vol. 15 [art. nr] 1426635, s. 1-12, 46, https://www.frontiersin.org/journals/immunology/articles/ 10.3389/fimmu.2024.1426635/full. DOI: 10.3389/fimmu.2024.1426635
Stereotactic radiosurgery in the treatment of essential tremor — a systematic review. MATEUSZ BILSKI, KATARZYNA SZKLENER, SEBASTIAN SZKLENER, ANNA RUDZIŃSKA, NATALIA KLUZ, JAKUB KLAS, ANNA RODZAJEWSKA, WERONIKA KURYŁO, MATEUSZ KORGA, IZABELA BARANOWSKA, SŁAWOMIR MAŃDZIUK. Front. Neurol. 2024 vol. 15 [art. nr] 1370091, s. 1-9, 47, https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1370091/full. DOI: 10.3389/fneur.2024.1370091
Results of metastasis directed therapy (MDT) performed with brachytherapy/interventional radiotherapy in patients with liver metastases from colorectal cancer in repeat oligopersistence clinical scenario: A single institution retrospective analysis. Mateusz BILSKI, Łukasz KUNCMAN, Jacek FIJUTH, Paweł CISEK. Ann. Oncol. 2024 vol. 35 suppl. 1 s. S50, ESMO Congress 2024. Munich, 26-29 June 2024. https://www.annalsofoncology. org/article/S0923-7534(24)00257-6/fulltext. DOI: 10.1016/j.annonc.2024.05.118
Stereotactic radiotherapy (SBRT) in the treatment of primary localized renal cell carcinoma (RCC) — a systematic review and meta-analysis. AGATA SULEJA, MATEUSZ BILSKI, LAUKHTINA EKATERINA, PAWEŁ RAJWA, KONRAD STAWISKI, MARCIN MISZCZYK. Nowotwory Biul. Pol. Tow. Onkol. 2024 vol. 9 supl. 1 s. 22, Studenckie Onko-Forum 2024. Warszawa, 25-26 maja 2024
Brachytherapy in the treatment of liver lesions. Mateusz Bilski. IV-th RART The Art of Recurrence Treatment (Recurence after Radiation Therapy) congress endorsed by ESTRO. 12-13.04.24 r. Katowice. Poland
Computer aided target volume delineation for postoperative radiation therapy in brain glioma patients with the use of the hybrid Artificial Intelligence model. Mateusz Bilski, Mateusz Bułat, Magdalena Peszyńska-Piorun, Izabela Baranowska, Jacek Fijuth, Łukasz Kuncman, Janusz Jurek. International Conference on Radiation Applications (RAP 2024). Granada, June 10-12, 2024 [online]. Abstr s. 174. https://www.rap-conference.org/24/index.php?page=boa
miR-200 family members predict overall survival of patients with WHO G2/WHO G3 brain gliomas. Mateusz Bilski, Marzanna Ciesielka, Magdalena Orzechowska, Bożena Jarosz, Paulina Całka, Agata Banach, Gabriela Czaja, Jacek Fijuth, Łukasz Kuncman. ESTRO 2024, 03-07.05.24 r. Glasgow, Scotland
Predictors of successful response to SBRT in PSMA PET/CT staged oligorecurrent prostate cancer. international multi-center analysis. Timo FW Soeterik, Marcin Miszczyk, Justyna Kociolek, Giulio Francolini, Pietro Garlatti, Mateusz Bilski, Eline Huele, Jochem RN van der Voort van Zyp, Wietse Eppinga, Joanne M van der Velden. ESTRO 2024, 03-07.05.24 r. Glasgow, Scotland
International Study on Radiosurgery of Prostate Cancer: Interim Report of the ISRS Working Group on Prostate Radio surgery. Treatment of intermediate unfavorable, high- and very-high risk prostate cancer with radio surgery. Maris Mezeckis, Aleksandra Napieralska, MarcinMiszczyk, Ferenc Lakosi, Mateusz Bilski, Grzegorz Woźniak, Vladislav Buryk, SofijaStrutinska, Sandra Ledin, Sofia Strutinska. 18-20.12.23 r. Stambul, Turkey
Interventional radiotherapy/brachytherapy in secondary liver malignancies from CRCLublin/Poland experience. Mateusz Bilski, Paweł Cisek. GI GEC ESTRO working group meeting.16.11.23 r., Prague, Czech Republic
Enhancing glioblastoma treatment through the integration of tumor-treating fields. [AUT.] KATARZYNA SZKLENER, MATEUSZ BILSKI, [AUT. KORESP.] KAROLINA NIEOCZYM, [AUT.] DOMINIKA MAŃDZIUK, SŁAWOMIR MAŃDZIUK. Front. Oncol.[online] 2023 vol. 13 [art. nr] 1274587, s. 1-10, bibliogr, [przeglądany 19 października 2023]. Dostępny w: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1274587. DOI: 10.3389/fonc.2023.1274587
Keynote speaker: Re-irradiation in the treatment of glioblastoma — a systematic review. [AUT.] MATEUSZ BILSKI, JAKUB KLAS, EMILIA KOWALCZYK, SYLWIA KOZIEJ, KATARZYNA KULSZO. W: 2nd International Conference on Addiction and Psychiatry, Naurology and Brain Disorders. London, November 20-21, 2023. [Abstr.] s. 23-24, bibliogr
The use of stereotactic radiotherapy in the treatment of patients with 5 or more brain metastates – systematic review. [AUT.] MATEUSZ BILSKI, MATEUSZ KORGA, KATARZYNA ZYCH, INGA ŁUCZKOWSKA, BARTOSZ PŁASKA, LUDMIŁA GRZYBOWSKA-SZATKOWSKA. W: 2nd International Conference on Addiction and Psychiatry, Naurology and Brain Disorders. London, November 20-21, 2023. [Abstr.] s. 39-40, bibliogr
Organizing Committee Member of 2nd International Conference on Addiction and Psychiatry, Naurology and Brain Disorders. London, November 20-21, 2023
Stereotactic radiotherapy as a modern tool in the treatment of kidney cancer. Mateusz Bilski. The 5th Urooncological Conference in Przemyśl — well-thought-out cooperation. 06/10/2023.
Chair of an oral session on medical and health sciences research: ICGOGCT 2023: 17.International Conference on Gastrointestinal Oncology and Gastrointestinal Cancer Treatments, August 10-11, 2023 in Venice, Italy
1st prize for the oral presentation entitled The Use of Brachytherapy in the Treatment of Liver Metastases: A Systematic Review. Mateusz Bilski, Jakub Klas, Emilia Kowalczyk, Sylwia Koziej, Katarzyna Kulszo, Ludmiła Grzybowska- Szatkowska. Gastrointestinal Oncology and Gastrointestinal Cancer Treatments. Venice / Italy, August 10-11, 2023
The use of stereotactic radiosurgery (SRS) in the treatment of essential tremor — a systematic review. [AUT.] MATEUSZ BILSKI, JAKUB KLAS, NATALIA KLUZ, ANNA RODZAJEWSKA, WERONIKA KURYŁO. In: International Conference on Addiction and Psychiatry & International Conference on Neurology and Brain Disorders. Paris, 23-24 March 2023. [Abstr.] s. 20
Brachytherapy in the treatment of non-melanoma skin peri-auricular cancers – a retrospective analysis of a single institution experience. MATEUSZ BILSKI, PAWEŁ CISEK, IZABELA BARANOWSKA, IZABELA KORDZIŃSKA-CISEK, NINA KOMANIECKA, ANNA HYMOS, EWELINA GRYWALSKA, [AUT. KORESP.] PAULINA NIEDŹWIEDZKA-RYSTWEJ. Cancers [online] 2022 vol. 14 nr 22 [art. nr] 5614, s. 1-17, https://www.mdpi.com/2072-6694/14/22/5614. DOI: 10.3390/cancers14225614
New directions in the therapy of glioblastoma. KATARZYNA SZKLENER, [AUT.] MAREK MAZUREK, MAŁGORZATA WIETESKA, MONIKA WACŁAWSKA, MATEUSZ BILSKI, SŁAWOMIR MAŃDZIUK. Cancers [online] 2022 vol. 14 nr 21 [art. nr] 5377, s. 1-39, https://www.mdpi.com/2072-6694/14/21/5377. DOI: 10.3390/cancers14215377
1st prize for the oral presentation entitled Application of stereotactic radiotherapy in the oligometastatic phase of bladder cancer dissemination. Rafał Wierciszewki, Beata Pająk, Alicja Tutkaj, Tutor: lek. Mateusz Bilski, MD. 10th MED-IQ conference. May 21, 22, Lublin
2nd prize for oral presentation entitled The use of stereotactic radiotherapy (SBRT) in the treatment of advanced pancreatic cancer – a review of the latest reports. Jakub Klas, Arkadiusz Grunwald, Klaudia Piwowar, Julia Wróbel, Katarzyna Nowak. Tutor: lek. Mateusz Bilski, 10th National Scientific Conference „Insight into Neogenesis”. Lublin, May 28, 2021
The role of conventionally fractionated radiotherapy and stereotactic radiotherapy in the treatment of carcinoid tumors and large-cell neuroendocrine cancer of the lung. [AUT.] MATEUSZ BILSKI, PAULINA MERTOWSKA, SEBASTIAN MERTOWSKI, MARCIN SAWICKI, ANNA HYMOS, PAULINA NIEDŹWIEDZKA-RYSTWEJ, EWELINA GRYWALSKA. Cancers [online] 2022 vol. 14 nr 1 [art. nr] 177, s. 1-17, bibliogr. poz. 90, [przeglądany 3 stycznia 2022]. Available in: https://www.mdpi.com/2072-6694/14/1/177.DOI: 10.3390/cancers14010177
The use of proton beam therapy in the postoperative treatment of primary glioblastoma. Krzysztof Lider, Arkadiusz Grunwald, Jakub Klas, Magdalena Olszówka, Michał Szymoniuk, Tutor: Mateusz Bilski. 9th Medical Simulation and Education Conference for Students and Young Physicians: MedIQ. Lublin, May 14-15, 2021
The use of stereotactic techniques in the treatment of recurrent glioblastoma multiforme. Krzysztof Lider, Jakub Klas, Michał Szymoniuk, Arkadiusz Grunwald, Marcin Narloch Tutor: Mateusz Bilski. 10th National Scientific Conference „Insight into Neogenesis”. Lublin, May 28, 2021
Combination of proton beam therapy and immunotherapy in the treatment of cancer. Krzysztof Lider. Tutor: Mateusz Bilski. VIII Scientific Conference: Health-promoting behaviors of high school and college students. Lublin, May 13-14, 2022
The use of carbon ion therapy in the treatment of cancer. Krzysztof Lider. Tutor: Mateusz Bilski. VIII Scientific Conference: Health-promoting behaviors of high school and college students. Lublin, May 13-14, 2022
The use of radiosensitizers in radiotherapy of glioblastoma. Krzysztof Lider . Tutor: Mateusz Bilski. Medical Simulation and Education Conference for Students and Young Physicians: MedIQ. Lublin, May 19-21, 2022
The role of radiotherapy in the treatment of kidney cancer. Mateusz Bilski. The 3rd Urooncological Conference in Przemyśl -well-thought-out cooperation.08/10/2022
The author of the lecture entitled Pregabalin for the treatment of neuropathic pain in patients undergoing radiation therapy for genitourinary malignancies. Webinar organized with Vipharm. Lublin. June 30, 2021
Interstitial HDR brachytherapy in the treatment of non-melanocytic skin cancers around the eye. [AUT.] PAWEŁ CISEK, DARIUSZ KIESZKO, MATEUSZ BILSKI*, RADOMIR DĘBICKI, EWELINA GRYWALSKA, RAFAŁ HRYNKIEWICZ, DOMINIKA BĘBNOWSKA, IZABELA KORDZIŃSKA-CISEK, AGNIESZKA ROLIŃSKA, PAULINA NIEDŹWIEDZKA-RYSTWEJ*, LUDMIŁA GRZYBOWSKA-SZATKOWSKA. Cancers [online] 2021 vol. 13 nr 6 [art. nr] 1425, s. 1-9, bibliogr. poz. 38, [przeglądany 23 marca 2021]. Available in: https://www.mdpi.com/2072-6694/13/6/1425. DOI: 10.3390/cancers13061425
The author of the chapter entitled The use of radiotherapy in the treatment of mild diseases of the locomotor system. Mateusz Bilski, Paweł Cisek. In the textbook: Oncoreumatologia. Contemporary challenges. Edited by prof. dr. hab. n. med. Maria Majdan and dr hab. n. med. Ludmiła Grzybowska-Szatkowska. PZWL Medical Publishing House. 1, 2021
Application of radiotherapy in the oligometastatic phase of dissemination of prostate cancer. Mateusz Bilski, Ewelina Kleczkowska, Krzysztof Patyra. II Urooncological Conference in Przemyśl 06-07.10.2020
An open doctoral dissertation on the basis of the initiated clinical study: „The expression of miR-200 as a predictive factor of survival of patients with brain WHO II and WHO III gliomas” — the study was awarded in the form of funding by the Fundacja im. Jakub count Potocki. Supervisor: Prof. dr hab. Jacek Fijuth
Malignancy-transformed mature cystic teratoma surgical treatment requires comprehensive staging procedures including pelvic / paraaortic lymphadenectomy. B. Barczyński, K. Frąszczak, M. Bilski, J. Szumiło, I. Wertel, M. Sobstyl, G. Polak, L. Grzybowska-Szatkowska, J. Kotarski. Eur. J. Gynecol. Oncol. 2020, Vol. 41 (3): 484-488. DOI: 10.31083 / j.ejgo.2020.03.5146
Clinical complete response after radiochemotherapy due to FIGO IV stage gynecological cancers – response evaluation and replanning during course of radiation therapy. [AUT.] MATEUSZ BILSKI, ANDRZEJ KUKIEŁKA, MONIKA BILSKA, BARTŁOMIEJ BARCZYŃSKI, KRZYSZTOF PATYRA. In: ESGE 28th Annual Congress. Thessaloniki, 6th – 9th October 2019. Abstr [b. pag.]
Clinical significance of IL-6 level in plasma and peritoneal fluid in patients with ovarian cancer. [AUT.] MONIKA BILSKA, IWONA WERTEL, MATEUSZ BILSKI, ANNA PAWŁOWSKA, DOROTA SUSZCZYK, JAN KOTARSKI. In: ESGE 28th Annual Congress. Thessaloniki, 6th – 9th October 2019. Abstr [b. pag.].
Chair of an oral session on oncological radiotherapy and radiotherapy during the international congress RAD2019: Seventh International Conference on Radiation and Applications in Various Fields of Research. Herceg Novi, Montenegro. June 10-14, 2019
High fraction doses for glioma treatment — An alternative for selected patients. Mateusz Bilski, Anna Rycyk, Piotr Kozłowski, Karolina Szymańska, Ludmiła Grzybowska-Szatkowska. W: RAD2019 : Seventh International Conference on Radiation and Applications in Various Fields of Research. Herceg Novi, Montenegro. 10.06-14.06.2019
Radiation induced bystander effect — Pros and cons. Mateusz Bilski, Karolina Brzozowska, Kamila Masłowska, Monika Bilska, Ludmiła Grzybowska- Szatkowska. W: RAD2019:Seventh International Conference on Radiation and Applications in Various Fields of Research. Herceg Novi, Montenegro. 10.06-14.06.2019
High precision in the treatment of patients with prostate cancer. Eweilna Węgielska, Krzysztof Patyra, Mateusz Bilski, Dariusz Garmol. Lecture presented at the scientific symposium High Precision Radiotherapy during the 16th Congress of the Polish Society of Medical Physics. Gliwice. June 13, 2019
Application of stereotaxic radiotherapy in the treatment of pituitary tumors. Małgorzata Mazur, Izabela Leśkiewicz, Mateusz Bilski, Ludmiła Grzybowska-Szatkowska. Chapter in: Challenges of modern hematology and oncology. Editors: Paulina Stefaniuk, Agnieszka Wójtowicz, Robert Ściślak. TYGIEL Scientific Publisher. Lublin 2019. ISBN: 978- 83- 65932-77-8
BRCA1 and BRCA2 mutations — a problem not only „female”, ie about genetic aberrations in prostate cancer. Paulina Stefaniuk, Mateusz Bilski, Monika Ruszała, Ludmiła Grzybowska-Szatkowska. Chapter in: Challenges of modern hematology and oncology. Editors: Paulina Stefaniuk, Agnieszka Wójtowicz, Robert Ściślak. TYGIEL Scientific Publisher. Lublin 2019. ISBN: 978- 83- 65932-77- 8
Lecturer during the specialization course: Basics of cancer radiotherapy. The course is intended for doctors specializing in modular specialization programs (qualified for specialization after 01/10/2014) in the field of oncological gynecology. Organizer: CMKP and the Medical University of Lublin; 1st Department of Oncological Gynecology and Gynecology; ul. Staszica 16, 20-081 Lublin. Course leader: prof. dr hab. n. med. Jan Kotarski.
Topics of lectures:
1. Fundamentals of the physics of ionizing radiation.
2. Fundamentals of radiobiology.
3. Radiation protection.
4. Principles of radical and palliative endometrial cancer treatment — teletherapy.
5. 5. Principles of radical and palliative cervical cancer treatment — teletherapy.
6. Principles of radical and palliative breast cancer treatment — teletherapy.
Author and member of the research team of an international clinical trial: „Assessment of the predictive values of selected immunological parameters and potential toxicity in patients undergoing brachytherapy for liver tumors.” — the study is in progress. Approval of the bioethics committee No.KE-0254/249/2018
The author and member of the research team of the clinical trial: „Assessment of the importance of humoral and cellular responses to Epstein-Barr virus infection in patients with breast cancer and diffuse large B-cell lymphoma” — the study has been completed. Awaiting publication of the results
First prize winner for the oral presentation „Stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic disease-systematic review”. In: 5th Lublin International Medical Congress. 30.11- 01.12.2018 Lublin
Winner of the 3rd prize for the oral presentation entitled „The use of stereotactic radiotherapy in the treatment of neoplasms in the oligometastatic phase of dissemination on the example of selected neoplastic diseases” in the session: Solid neoplasms at the Interdisciplinary Scientific and Training Conference „Challenges of modern hemtaology and oncology”. 17/11/2018 Lublin
BRCA1 and BRCA2 mutations — a problem not only „female”, ie about genetic aberrations in prostate cancer. [AUT.] PAULINA STEFANIUK, MATEUSZ BILSKI, LUDMIŁA GRZYBOWSKA-SZATKOWSKA. In: Interdisciplinary Scientific and Training Conference „Challenges of modern hematology and oncology”. Lublin, November 17, 2018 [online]. Ed. Karolina Widłak, Paulina Stefaniuk. Abstr pp. 42-43, [reviewed November 23, 2018]. Available at: http://www.wyzienia.umlub.pl/ksiazka-abstraktow/. Lublin 2018, 978-83-952872-0-6
Metastatic breast cancer to the stomach — case report and literature review. [AUT.] PAULINA STEFANIUK, MATEUSZ BILSKI, PIOTR KOZŁOWSKI, MONIKA BILSKA, LUDMIŁA GRZYBOWSKA-SZATKOWSKA. In: Selected disease entities and conditions – scientific review [online]. Ed. Monika Maciąg, Kamil Maciąg Lublin 2018, TYGIEL Scientific Publishing House, pp. 90-96, bibliogr. sum, [accessed September 25, 2018]. Available at: http://bc.wydawnictwo-tygiel.pl/publikacja/47D02141-C733-AE4B-1EFE-8C15E86991D6, 978-83-65932-47-1
Second primary cancer after rectal cancer. [AUT.] MAŁGORZATA JANKIEWICZ, FRANCISZEK BURDAN, MATEUSZ BILSKI, PIOTR KOZŁOWSKI, MAGDALENA KOZŁOWSKA, MONIKA BILSKA. W: [12th] European Colorectal Congress : Personalized colorectal surgery, new technologies, complications in colorectal surgery. St. Gallen, 3-6 December 2018 [online]. [Abstr.] s. 26, https://www.colorectalsurgery.eu/abstract-submissioncopy
Analysis of the effectiveness of teleradiotherapy with modulation of beam intensity in the extramedullary plasmacytoma of the head and neck region: A new look at inductive systemic treatment. [AUT.] MATEUSZ BILSKI, LUDMIŁA GRZYBOWSKA-SZATKOWSKA, EWELINA GRYWALSKA, DARIUSZ SURDYKA, MONIKA BILSKA, PAULINA KOZAKIEWICZ, PAWEŁ KORONA, JACEK ROLIŃSKI. Post. Hig. Med. Dośw. [online] 2018 t. 72 s. 884-890, bibliogr. poz. 38, https://phmd.pl/resources/html/article/details?id=181860. DOI: 10.5604/01.3001.0012.6532
1 Award for the best oral presentation — http://rad2018.rad-conference.org/awards.php.Abscopal effect of radiotherapy — The pursuit of the unknown. Mateusz Bilski, Paulina Stefaniuk, Michał Jędrejek, Paweł Cisek, Monika Bilska, Izabela Cisek, and Ludmiła Grzybowska-Szatkowska. In: RAD2018: Sixth International Conference on Radiation and Applications in Various Fields of Research. Ohrid, Macedonia. 18.06-22.06.2018
3D-HDR intraluminal brachytherapy in oesophageal cancer. Paweł Cisek, Dariusz Kieszko, Mateusz Bilski, Izabela Kordzińska-Cisek, Paulina Kozakiewicz, Ludmiła Grzybowska-Szatkowska. In: RAD2018: Sixth International Conference on Radiation and Applications in Various Fields of Research. Ohrid, Macedonia. 18.06-22.06.2018
Great effect of radiation therapy with neoadjuvant immunochemotherapy in a patient with extramedullary plasmacytoma of the maxillary sinus – A case report. Mateusz Bilski, Anna Rycyk, Michał Janiszewski, Paulina Kozakiewicz, Paweł Cisek, Anna Brzozowska, and Ludmiła Grzybowska-Szatkowska. In: RAD2018: Sixth International Conference on Radiation and Applications in Various Fields of Research. Ohrid, Macedonia. 18.06-22.06.2018
Influence of PET-CT on irradiation volume target determination based on patient case analysis with locally advanced esophageal cancer. Michał Janiszewski, Agnieszka Janiszewska, Mateusz Bilski, Paweł Cisek, Paulina Kozakiewicz, Izabela Kordzińska-Cisek, and Ludmiła Grzybowska-Szatkowska. In: RAD2018: Sixth International Conference on Radiation and Applications in Various Fields of Research. Ohrid, Macedonia. 18.06-22.06.2018
Brachytherapy in penile cancer as an alternative to surgical treatment – a case report and analysis of the literature. [AUT.] IZABELA KORDZIŃSKA, PAULINA KOZAKIEIWICZ, PAWEŁ CISEK, DARIUSZ KIESZKO, MATEUSZ BILSKI, MICHAŁ JANISZEWSKI, LUDMIŁA GRZYBOWSKA-SZATKOWSKA. Onkol. Radioter. 2018 R. 12 No. 1 pp. 37-43, 73-79
Adjuvant radiochemotherapy with a 23-month general survival time in a patient due to splenic hemangiosarcoma rupture: A case report with the literature review. MATEUSZ BILSKI, DARIUSZ SURDYKA, IWONA PAŚNIK, MONIKA BILSKA, PAWEŁ CISEK, PAWEŁ KORONA, JUSTYNA SZUMIŁO, LUDMIŁA GRZYBOWSKA-SZATKOWSKA. Case Rep. Oncol. Med. [online] 2018 vol. 2018 [art. No.] ID 8672407, pp. 1-5. Available in: https://doi.org/10.1155/2018/8672407
Effective polypharmacotherapy in a patient with diabetic peripheral neuropathy and phantom pain. [AUT.] MATEUSZ BILSKI, ANNA RYCYK, JOANNA RUSZCZYK, MONIKA BILSKA, BARBARA KOSZŁA. At: 21st Century Medicine-International Medical Congress for Students and Young Doctors. Lublin, 7th April 2018. Abstr. p. 71
1 Award for presentation Interleukin 17A as a factor differentiating benign and malignant tumors of the ovary. In: V Congress of the Polish Society of Oncological Gynecology. Lublin. 30.09.2017
Biochemical liver function markers after CT-guided brachytherapy for liver metastases. (Evaluation of liver biochemical parameters after brachytherapy of liver metastases under CT control.) [AUT.] PAWEŁ CISEK, IZABELA KORDZIŃSKA-CISEK, ŁUKASZ CHARKOT, PAWEŁ KORONA, DARIUSZ KIESZKO, MATEUS BILSKI, ANNA BRZOZOWSKA, MICHAŁ JANISZEWSKI, LUDMIŁA GRZYBOWSKA-SZATKOWSKA. Onkol. Radioter. 2017, No. 11, No. 1 pp. 34-42, 67-75, bibliogr., [Text in parallel] in English half.]
Methods to increase the radiosensitivity of the squamous cell region of the head and neck (HNSCC) by affecting the tumor microenvironment. (AUTHORS) PAULINA STEFANIUK, MATEUSZ BILSKI, DOMINIKA SZYMCZYK, MAGDALENA SZYDEŁKO, MONIKA RUSZAŁA (Methods of enhancing radiosensitivity of head and neck squamos cell carcinoma by affecting the tumor microenvironment). In: II National Scientific Conference: Dimensions of civilization and social diseases of the 21st century. Lublin, 7 April 2017. [Abstract], pp. 44-45, [Text parallel. in English ang.]
The importance of natural and chemical radiosensitizers in the treatment of pancreatic cancer – an overview of the latest scientific reports. [AUT.] MAGDALENA SZYDEŁKO, MATEUS BILSKI, DOMINIKA SZYMCZYK, ANNA SZEWCZYK, MONIKA RUSZAŁA. In: IX Interdisciplinary Scientific Conference TYGIEL 2017: Interdisciplinary the key to development. Lublin, 18-19 March 2017. Abstr. pp. 134-135
The guided brachytherapy of metastasis to the liver. [AUT.] PAWEŁ CISEK, IZABELA CISEK, ANNA BRZOZOWSKA, ŁUKASZ CHARKOT, PAWEŁ KORONA, MATEUSZ BILSKI, DARIUSZ KIESZKO, LUDMIŁA GRZYBOWSKA-SZATKOWSKA. In: RAD2017: Fifth International Conference on Radiation and Applications in Various Fields of Re- search. Budva, 12.06-16.06.2017. Abstr. p. 449. – Mateusz Bilski – PERSON PRESENTING WORK
Glioblastoma multiforme — attempts at diminishing radioresistance. [AUT.] DOMINIKA SZYMCZYK, MATEUSZ BILSKI, MAGDALENA SZYDEŁKO, ANNA SZEWCZYK, MONIKA RUSZAŁA, PAULIN STEFANIUK. At: 21st Century Medicine: International Medical Congress for Students and Young Doctors. Lublin, 31st March – 1st April 2017. Abstr. pp. 78-79
CXCR4 receptor breakthrough in cancer diagnostics and therapy? Review of the latest scientific reports – on the example of breast cancer, prostate cancer and glioblastoma multiforme. [AUT.] DOMINIKA SZYMCZYK, MATEUSZ BILSKI, MAGDALENA SYZYDKO, MONIKA RUSZEWA, ANNA SZEWCZYK. In: NoMAD: Conference for students and young scientists. Lublin, March 24-25, 2017. [Abstract], p. 14
Selected neoplastic diseases in the inhabitants of the Podkarpackie Voivodeship in the years 1999-2011. (AUTHORIZED BY KRZYSZTOF BILSKI, MATEUSZ BILSKI. In: Environmental health threats in society. Ed. sciences. Małgorzata Marć, Monika Binkowska-Bury, and Paweł Januszewicz. Rzeszów 2016, Wydawnictwo Uniwersytetu Rzeszowskiego, pp. 197-207, bibliogr. sum, Public Health; part. 5, 978-83-7996-314-0
Assessment of peripheral blood and bone marrow T, NK, NKT and dendritic cells in patients with multiple myeloma. (Evaluation of T, NK, NKT lymphocytes and dendritic cells in the peripheral blood and bone marrow of patients with multiple myeloma. [AUT.] MARCIN PASIARSKI, EWELINA GRYWALSKA, AGATA KOSMACZEWSKA, STANISŁAW GÓŹDŹ, PAWEŁ STECKIEWICZ, BARTOSZ GARUS, MATEUSZ BILSKI, ANNA HYMOS , JACEK ROLIŃSKI, MICHAŁ ZGURSKI. Post. Hig. Med. Exp. 2015, vol. 69 [none], pp. 1435-1442, b. Pos. 47
Prognostic value of selected immunological factors in patients with ovarian cancer. MONIKA BILSKA, IWONA WERTEL, JUSTYNA SURÓWKA, KAROLINA OKŁA, MATEUSZ BILSKI, RAFAŁ TARKOWSKI, JAN KOTARSKI. Tabes. Bow. 2015 vol. 68 No. 4 part 2 pp. 690-694, b. Pos. 30, sums
Use of oxycodone with naloxone in the treatment of pain therapy and reversal of adverse effects of opioids on the digestive system – case report. (AUT.] MATEUSZ BILSKI *, MONIKA BILSKA, PAWEŁ KLIMKOWICZ, BARBARA KOSZŁA (The application of oxycodone with ophthalmone on the human digestive system – case report.) Anestezjol. Rat. 2015 vol. 9 pp. 395-399, b. catfish
Cetuximab in head and neck cancer therapy. (Cetuximab in the treatment of head and neck cancer.) [AUT.] M. PILECKA, A. STRĄK, P. KOZAKIEWICZ, MATEUSZ BILSKI, PAWEŁ CISEK, ANNA BRZOZOWSKA, M ARIA MAZURKIEWICZ, LUDMIŁA GRZYBOWSKA-SZATKOWSKA. Onkol. Radioter. 2015, No. 9, No. 4 pp. 34-38, 64-68, the Bibliogroup, [Text in parallel in English half.]
Natural killer and natural killer. T-like cells in splenectomised patients. [AUT.] EWELINA GRYWALSKA, JUSTYNA MARKOWICZ, DOROTA SIWICKA *, MARCIN PASIARSKI, AGATA SURDACKA, AGNIESZKA GRAFKA, AGNIESZKA MALEC, MATEUS BILSKI, TOMASZ ROMAN, JACEK ROLINSKI. Centr. Eur. J. Immunol. 2013 vol. 38, No. 3 pp. 372-379, b. Pos. 65
Someone had a stab at experimenting with drugs (ECG-gated CT in the recovery of a suicidal attempt). [AUT.] KATARZYNA JASIŃSKA, IGA KLONOWSKA, MATEUSZ BILSKI. In: 1st Clinical Case Studies International Students’ Conference, Lublin, May 25-26, 2012. [Abstr.] P. 57
